Wahid Wassef1, John DeWitt2, Kathleen McGreevy2, Mel Wilcox3, David Whitcomb4, Dhiraj Yadav4, Stephen Amann5, Girish Mishra6, Samer Alkaade7, Joseph Romagnuolo8, Tyler Stevens9, John Vargo9, Timothy Gardner10, Vikesh Singh11, Walter Park12, Celia Hartigan1, Bruce Barton1, Carol Bova1. 1. University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2. Indiana University Medical Center, Indianapolis, Indiana, USA. 3. University of Alabama School of Medicine, Birmingham, Alabama, USA. 4. UPMC Presbyterian, Pittsburgh, Pennsylvania, USA. 5. Digestive Health Specialists, Tupelo, Mississippi, USA. 6. Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. 7. Saint Louis University School of Medicine, St Louis, Missouri, USA. 8. Palmetto Health Richland, Columbia, South Carolina, USA. 9. Cleveland Clinic Foundation, Cleveland, Ohio, USA. 10. Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 11. Johns Hopkins Medical Hospital, Baltimore, Maryland, USA. 12. Stanford University School of Medicine, Stanford, California, USA.
Abstract
OBJECTIVES: Chronic pancreatitis is a significant medical problem that impacts a large number of patients worldwide. In 2014, we developed a disease-specific instrument for the evaluation of quality of life in this group of patients: pancreatitis quality of life instrument (PANQOLI). The goal of this study was to evaluate its psychometric properties: its reliability and its construct validity. METHODS: This is a cross-sectional multi-center study that involved 12 pancreatic disease centers. Patients who met the inclusion/exclusion criteria for chronic pancreatitis were invited to participate. Those who accepted were asked to complete seven questionnaires/instruments. Only patients who completed the PANQOLI were included in the study. Its reliability and its construct validity were tested. RESULTS: A total of 159 patients completed the PANQOLI and were included in the study. They had a mean age of 49.03, 49% were male, and 84% were Caucasian. Six of the 24 items on the scale were removed because of lack of inter-item correlation, redundancy, or lack of correlation to quality of life issues. The final 18-item scale had excellent reliability (Cronbach's alpha coefficient: 0.914) and excellent construct validity with good correlation to generic quality of life instruments (SF-12 and EORTC QLQ-C30/QLQ-PAN26) and lack of correlation to non-quality of life instruments (MAST and DAST). Through exploratory factor analysis, the PANQOLI was found to consist of four subscales: emotional function scale, role function scale, physical function scale, and "self-worth" scale. CONCLUSIONS: PANQOLI is the first disease-specific instrument to be developed and validated for the evaluation of quality of life in chronic pancreatitis patients. It has a unique subscale for "self-worth" that differentiates it from other generic instruments. Studies are currently under way to evaluate its use in other populations not included in this study.
OBJECTIVES:Chronic pancreatitis is a significant medical problem that impacts a large number of patients worldwide. In 2014, we developed a disease-specific instrument for the evaluation of quality of life in this group of patients: pancreatitis quality of life instrument (PANQOLI). The goal of this study was to evaluate its psychometric properties: its reliability and its construct validity. METHODS: This is a cross-sectional multi-center study that involved 12 pancreatic disease centers. Patients who met the inclusion/exclusion criteria for chronic pancreatitis were invited to participate. Those who accepted were asked to complete seven questionnaires/instruments. Only patients who completed the PANQOLI were included in the study. Its reliability and its construct validity were tested. RESULTS: A total of 159 patients completed the PANQOLI and were included in the study. They had a mean age of 49.03, 49% were male, and 84% were Caucasian. Six of the 24 items on the scale were removed because of lack of inter-item correlation, redundancy, or lack of correlation to quality of life issues. The final 18-item scale had excellent reliability (Cronbach's alpha coefficient: 0.914) and excellent construct validity with good correlation to generic quality of life instruments (SF-12 and EORTC QLQ-C30/QLQ-PAN26) and lack of correlation to non-quality of life instruments (MAST and DAST). Through exploratory factor analysis, the PANQOLI was found to consist of four subscales: emotional function scale, role function scale, physical function scale, and "self-worth" scale. CONCLUSIONS: PANQOLI is the first disease-specific instrument to be developed and validated for the evaluation of quality of life in chronic pancreatitispatients. It has a unique subscale for "self-worth" that differentiates it from other generic instruments. Studies are currently under way to evaluate its use in other populations not included in this study.
Authors: Siwar Albashir; Mary P Bronner; Mansour A Parsi; R Matthew Walsh; Tyler Stevens Journal: Am J Gastroenterol Date: 2010-07-06 Impact factor: 10.864
Authors: M Wehler; U Reulbach; R Nichterlein; K Lange; B Fischer; M Farnbacher; E G Hahn; T Schneider Journal: Scand J Gastroenterol Date: 2003-10 Impact factor: 2.423
Authors: Henrica C de Vet; Caroline B Terwee; Raymond W Ostelo; Heleen Beckerman; Dirk L Knol; Lex M Bouter Journal: Health Qual Life Outcomes Date: 2006-08-22 Impact factor: 3.186
Authors: Mark E Lowe; Marc T Goodman; Gregory A Coté; Marshall J Glesby; Mark Haupt; Nicholas J Schork; Vikesh K Singh; Dana K Andersen; Stephen J Pandol; Aliye Uc; David C Whitcomb Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Christopher E Forsmark; Dana K Andersen; John T Farrar; Megan Golden; Aida Habtezion; Sohail Z Husain; Liang Li; Julia Mayerle; Stephen J Pandol; Aliye Uc; Zixi Zhu; Dhiraj Yadav Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Gregory A Coté; Dhiraj Yadav; Judah A Abberbock; David C Whitcomb; Stuart Sherman; Bimaljit S Sandhu; Michelle A Anderson; Michele D Lewis; Samer Alkaade; Vikesh K Singh; John Baillie; Peter A Banks; Darwin Conwell; Nalini M Guda; Thiruvengadam Muniraj; Gong Tang; Randall Brand; Andres Gelrud; Stephen T Amann; Christopher E Forsmark; Mel C Wilcox; Adam Slivka; Timothy B Gardner Journal: Am J Gastroenterol Date: 2018-06-05 Impact factor: 10.864
Authors: Asbjørn M Drewes; Anne E Olesen; Adam D Farmer; Eva Szigethy; Vinciane Rebours; Søren S Olesen Journal: Nat Rev Dis Primers Date: 2020-01-06 Impact factor: 52.329